Regen BioPharma Inc (RGBP)

[RoagTrader]

The DTC issue has nothing to do with an acquisition so let's drop that. All of the clients of the transfer agent RGBP uses show 0 held at DTC (obviously all of these companies aren't being acquired).

Now, forgetting the DTC, will RGBP be acquired? It seems likely, everything they've done these past few months, particularly reviving those old patents, points in that direction. Once we get filings we'll know more and that will be the next big catalyst no matter what. The company has funding, their IP is extremely valuable, and the bio sector is hot. A large pharma can easily pay a substantial price for RGBP just to have the IP in their portfolio.